Position in MDXH
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$25,325
New position
Shares Held
11,011
first reported quarter
Ownership
0.012%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2026
1 quarter on record
Voting authority
Sole 100%
Shared 0%
None 0%
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026PEAPACK GLADSTONE FINANCIAL CORP holds $60,457,705 across 8 Diagnostics & Research names.
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LH |
Labcorp Holdings Inc.
|
89,218 | $24,981,040 | |
| 2 | TMO |
Thermo Fisher Scientific Inc.
|
43,284 | $21,700,865 | |
| 3 | DHR |
Danaher Corp /De/
|
43,427 | $8,271,974 | |
| 4 | DGX |
Quest Diagnostics Inc
|
10,620 | $2,250,908 | |
| 5 | WAT |
Waters Corp /De/
|
5,688 | $2,133,226 | |
| 6 | IDXX |
Idexx Laboratories Inc /De
|
724 | $381,142 | |
| 7 | IQV |
Iqvia Holdings Inc.
|
1,938 | $374,460 | |
| 8 | MTD |
Mettler Toledo International Inc/
|
285 | $364,090 |
All Filings in MDXH
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $25,325 | 11,011 | Shares | Defined | 2026-05-15 | |
| No filing history on record for this holder in this stock. | ||||||